Patient L2 had a KRAS-mutated tumor, and patient L4 had a MET-amplified tumor, while no known oncogenic driver alteration was detected for patient L3 (Supplemental Table 1 and Supplemental Figure 2A). Here, KRAS is linked to neoplasm.